Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00756925 · ClinicalTrials.gov registry record
Gender and Neural Substrates of Stress and Craving
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 19
- Enrollment target
NCT00756925 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 19 participants.
The verdict
NCT00756925 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
Cocaine dependence is an insidious disease underscored by a powerful proclivity to relapse despite an individual's ability to recognize the deleterious consequences of continued drug use. To date, there are only a limited number of treatments, and no FDA approved medications for the treatment of cocaine dependence. Attempts to find reliable and successful treatments for cocaine dependence may be marred by gender differences in brain chemistry, structure, and function that are manifested as drug craving and relapse. For example, cues, drug exposure, and stress promote relapse, yet females appear be more susceptible to stress induced relapse, while males may be more susceptible to cue induced relapse. Therefore identifying the neural substrates involved in processing the valence of internal and external stimuli may provide further insight into cocaine dependence and provide more effective therapeutic strategies aimed at preventing relapse. Corticotropin releasing hormone (CRH) is a pharmacological activator of the hypothalamic pituitary adrenal (HPA) axis, and has been implicated in stress induced drug relapse. Corticotropin releasing hormone receptors are located at extrahypothalamic brain nuclei that have been implicated in determining the significance of both internal (somatic) and external (environmental) stimuli. The primary directive of this pilot project is to utilize functional magnetic resonance imaging (fMRI) to identify possible brain nuclei associated with with stress induced drug craving in cocaine dependent females.
Interventions
- DRUG Acthrel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-02 |
| Est. Completion | 2010-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00756925
The ClinicalTrials.gov registry entry for NCT00756925 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acthrel is the first listed.
NCT00756925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00756925 about?
NCT00756925 is a clinical study titled "Gender and Neural Substrates of Stress and Craving". Cocaine dependence is an insidious disease underscored by a powerful proclivity to relapse despite an individual's ability to recognize the deleterious consequences of continued drug use. To date, there are only a limited number of treatments, and no FDA approved medications for the treatment of coc...
What is the current status of trial NCT00756925?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2009-02. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00756925?
The interventions under investigation include: Acthrel (DRUG).
Who is sponsoring clinical trial NCT00756925?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.